Literature DB >> 20724157

170th ENMC International Workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27-29 November 2009, Naarden, The Netherlands.

R Quinlivan1, N Shaw, K Bushby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20724157     DOI： 10.1016/j.nmd.2010.07.272

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  9 in total

1.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

Review 2.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

Review 3.  Multidisciplinary approach to the management of myopathies.

Authors:  Wendy M King; John T Kissel
Journal:  Continuum (Minneap Minn)       Date:  2013-12

Review 4.  Bone health and associated metabolic complications in neuromuscular diseases.

Authors:  Nanette C Joyce; Lauren P Hache; Paula R Clemens
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-17       Impact factor: 1.784

Review 5.  Optimizing Bone Health in Duchenne Muscular Dystrophy.

Authors:  Jason L Buckner; Sasigarn A Bowden; John D Mahan
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

6.  Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis - A cross sectional survey.

Authors:  F Danckworth; N Karabul; A Posa; F Hanisch
Journal:  Mol Genet Metab Rep       Date:  2014-02-11

7.  Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.

Authors:  K Tsaknakis; K Jäckle; K A Lüders; H M Lorenz; L Braunschweig; A K Hell
Journal:  Osteoporos Int       Date:  2022-05-18       Impact factor: 5.071

8.  The relationship of bone mineral density and vitamin D levels with steroid use and ambulation in patients with Duchenne muscular dystrophy.

Authors:  Filiz Meryem Sertpoyraz; Bedile İrem Tiftikçioğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-08-20

Review 9.  Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy.

Authors:  Ilaria Sanzarello; Luciano Merlini; Francesco Traina; Michele Attilio Rosa; Cesare Faldini
Journal:  Int Sch Res Notices       Date:  2014-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.